DekaBank Deutsche Girozentrale’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,167
Closed -$773K 1411
2022
Q1
$773K Sell
1,167
-166
-12% -$99.9K ﹤0.01% 962
2021
Q4
$915K Hold
1,333
﹤0.01% 951
2021
Q3
$972K Buy
1,333
+1,166
+698% +$795K ﹤0.01% 907
2021
Q2
$130K Hold
167
﹤0.01% 1300
2021
Q1
$130K Buy
+167
New +$129K ﹤0.01% 1256

Other funds holding OM

DekaBank Deutsche Girozentrale's OM Position: Q2 2022 in Review

DekaBank Deutsche Girozentrale sold out of Outset Medical (OM) in Q2 2022, closing a stake of 1,167 shares — an estimated $773K sold.

DekaBank Deutsche Girozentrale first reported a position in OM in Q1 2021 and held it in 5 quarters. The position peaked at $972K in Q3 2021. 149 funds tracked by Wall St. Rank hold OM as of Q2 2022.

  • DekaBank Deutsche Girozentrale reported no remaining Outset Medical position as of Q2 2022 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 1,167 Outset Medical shares in Q2 2022, an estimated $773K.
  • DekaBank Deutsche Girozentrale first reported a position in Outset Medical in Q1 2021 and held it in 5 quarters.
  • DekaBank Deutsche Girozentrale's Outset Medical position peaked at $972K in Q3 2021.
  • 149 funds tracked by Wall St. Rank held Outset Medical as of Q2 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2022, filed 3 Aug 2022.